SCHEMBL29640818

SCHEMBL29640818

Brc1ccc2c(c1)CN(c1ccnc(-c3ccncn3)n1)C2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 1/20 0.35
MAP3K14 Q99558 1/20 0.35
SORD Q00796 1/20 0.34
GSK3B P49841 5/20 0.33
CYP1A2 P05177 4/20 0.33
CYP3A4 P08684 4/20 0.33
CLK4 Q9HAZ1 3/20 0.33
ALDH1A1 P00352 3/20 0.33
HSD17B10 Q99714 3/20 0.33
CYP2D6 P10635 2/20 0.33
TSHR P16473 1/20 0.33
ASIC3 Q9UHC3 1/20 0.32
GSK3A P49840 1/20 0.32
CDK9 P50750 1/20 0.32
CDK5 Q00535 1/20 0.32
TAOK1 Q7L7X3 1/20 0.32
SCN9A Q15858 1/20 0.32
ALOX15 P16050 1/20 0.31
ROCK2 O75116 1/20 0.31
USP2 O75604 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29640835 0.85 ADORA2A (0.38) ROCK1SORDGSK3BCYP1A2CYP3A4
SCHEMBL29640772 0.84 CYP1A2 (0.39) SORDGSK3BCYP1A2CYP3A4CLK4
SCHEMBL29640770 0.82 ROCK2 (0.47) ROCK1GSK3BCYP1A2CYP3A4ALDH1A1
SCHEMBL29640917 0.82 TRPV3 (0.39) CYP1A2CYP3A4ALDH1A1HSD17B10CYP2D6
SCHEMBL22229640 0.69 ROCK2 (0.35) SCN9AROCK2
SCHEMBL29627931 0.69 TRPV1 (0.39) ROCK1CYP1A2CYP3A4ALDH1A1HSD17B10
SCHEMBL38655465 0.68 GRM5 (0.46) ALDH1A1MEN1KMT2A
SCHEMBL29640899 0.67 LATS1 (0.37) GSK3BCLK4ALDH1A1CYP2D6CDK9
SCHEMBL14838148 0.64 ASIC3 (0.37) ASIC3GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL22229617 0.63 GRM4 (0.31) SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114502163-A Ethynylheterocycles as RHO-related coiled coil kinase (ROCK) inhibitors 安吉昂生物医药公司 2022-05-13 CN disclosed